カテゴリ： MarketLine, ルクセンブルク, 企業調査

Eurofins Scientific SE：戦略・SWOT・企業財務分析

◆英語タイトル：Eurofins Scientific SE - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA8015743
◆発行会社（調査会社）：MarketLine
◆発行日：2017年9月30日
◆ページ数：50
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：ルクセンブルク
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Eurofins Scientific SE – Strategy, SWOT and Corporate Finance Report
Summary

Eurofins Scientific SE – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Eurofins Scientific (Eurofins or ‘the company’) is a life sciences company engaged in providing a range of analytical testing services to clients across multiple industries. The company operates in Europe, the Americas and Asia Pacific. It is headquartered in Luxembourg City, Luxembourg.

Scope

- Detailed information on Eurofins Scientific SE required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Eurofins Scientific SE in the form of a SWOT analysis
- An in-depth view of the business model of Eurofins Scientific SE including a breakdown and examination of key business segments
- Intelligence on Eurofins Scientific SE’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Eurofins Scientific SE, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Eurofins Scientific SE and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Eurofins Scientific SE as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Eurofins Scientific SE’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Eurofins Scientific SE: Company Overview
Eurofins Scientific SE: Overview and Key Facts
Eurofins Scientific SE: Overview
Eurofins Scientific SE: Key Facts
Eurofins Scientific SE: Key Employees
Eurofins Scientific SE: Key Employee Biographies
Eurofins Scientific SE: Major Products and Services
Eurofins Scientific SE: Company History
Eurofins Scientific SE: Management Statement
Eurofins Scientific SE: Locations and Subsidiaries
Eurofins Scientific SE: Key Competitors
Eurofins Scientific SE: Company Analysis
Eurofins Scientific SE: Business Description
Eurofins Scientific SE: SWOT Analysis
Eurofins Scientific SE: SWOT Overview
Eurofins Scientific SE: Strengths
Eurofins Scientific SE: Weaknesses
Eurofins Scientific SE: Opportunities
Eurofins Scientific SE: Threats
Eurofins Scientific SE: Corporate Financial Deals Activity
Eurofins Scientific SE: Financial Deals Overview
Eurofins Scientific SE: Targets and Partners
Eurofins Scientific SE: Top Deals 2013 – 2017YTD*
Eurofins Scientific SE: Advisors
Eurofins Scientific SE: Top Legal Advisors
Eurofins Scientific SE: Top Financial Advisors
Eurofins Scientific SE: Mergers and Acquisitions
Eurofins Scientific SE: Capital Raising
Eurofins Scientific SE: Private Equity and Ownership
Eurofins Scientific SE: Recent Developments
Eurofins Scientific SE: News and Events Summary
Eurofins Scientific SE: Business Expansion
Eurofins Scientific SE: Corporate Governance
Eurofins Scientific SE: Financial Performance
Eurofins Scientific SE: IT Spending Announcements
Eurofins Scientific SE: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Eurofins Scientific SE: Key Facts
Table 2: Eurofins Scientific SE: Key Employees
Table 3: Eurofins Scientific SE: Locations and Subsidiaries
Table 4: Eurofins Scientific SE: Key Competitors
Table 5: Eurofins Scientific SE: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Eurofins Scientific SE: M&A Activity by Geography (TTM*)
Table 7: Eurofins Scientific SE: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 8: Eurofins Scientific SE: M&A Average Deal Size - Value (US$m)
Table 9: Eurofins Scientific SE: Targets and Partners
Table 10: Eurofins Scientific SE: Top Deals 2013 - 2017YTD*
Table 11: Eurofins Scientific SE: Legal Advisor Ranking by Value (US$m)
Table 12: Eurofins Scientific SE: Financial Advisor Ranking by Value (US$m)
Table 13: Eurofins Scientific SE: M&A Volume and Value Trend (2013 - YTD*2017)
Table 14: Eurofins Scientific SE: M&A Activity by Geography (2013 - YTD*2017)
Table 15: Eurofins Scientific SE: Capital Raising Volume and Value Trend (2013 - YTD*2017)
Table 16: Eurofins Scientific SE: Capital Raising by Deal Type (2013 - YTD*2017)
Table 17: Eurofins Scientific SE: Private Equity and Ownership Volume and Value Trend (2013 - YTD*2017)
Table 18: Eurofins Scientific SE: Private Equity and Ownership Volume by Deal Type (2013 - YTD*2017)
Table 19: Eurofins Scientific SE: News and Events Summary
Table 20: Eurofins Scientific SE: Business Expansion
Table 21: Eurofins Scientific SE: Corporate Governance
Table 22: Eurofins Scientific SE: Financial Performance
Table 23: Eurofins Scientific SE: IT Spending Announcements
Table 24: Eurofins Scientific SE: Strategy and Operations

★海外企業調査レポート[Eurofins Scientific SE：戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Ford Motor Company：企業の戦略・SWOT・財務情報
    Ford Motor Company - Strategy, SWOT and Corporate Finance Report Summary Ford Motor Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Main Line Health System：企業の戦略的SWOT分析
    Main Line Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Grupo Farma：企業の戦略的SWOT分析
    Grupo Farma - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • KBC Group NV：企業のM&A・事業提携・投資動向
    KBC Group NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's KBC Group NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Evotec AG (EVT)：医療機器：M&Aディール及び事業提携情報
    Summary Evotec AG (Evotec) is a drug discovery alliance and development partnership company. It identifies and develops small molecule drugs across various therapeutic areas such as, cancer, neurological and nephrological conditions, cardiovascular, inflammation, pain, metabolic and respiratory dise …
  • The Arag Group：企業の戦略・SWOT・財務分析
    The Arag Group - Strategy, SWOT and Corporate Finance Report Summary The Arag Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Neurovance Inc-製薬・医療分野：企業M&A・提携分析
    Summary Neurovance Inc (Neurovance) is a clinical stage neuroscience focused company that develops centanafadine (CTN) SR for adult and pediatric Attention Deficit Hyperactivity Disorder (ADHD). CTN, formerly EB-1020, is a novel triple reuptake inhibitor that acts as a functional hybrid with activit …
  • Whataburger Restaurants LP：戦略・SWOT・企業財務分析
    Whataburger Restaurants LP - Strategy, SWOT and Corporate Finance Report Summary Whataburger Restaurants LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • AvStar Aviation Services Inc：企業の戦略的SWOT分析
    AvStar Aviation Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Zynerba Pharmaceuticals Inc (ZYNE)：企業の財務・戦略的SWOT分析
    Summary Zynerba Pharmaceuticals Inc (Zynerba Pharmaceuticals), formerly AllTranz Inc, is a developer of next-generation synthetic cannabinoid therapeutics. The company provides pipeline product candidates such as ZYN002 and ZYN001. Its ZYN002 is a synthetic CBD, a non-psychoactive cannabinoid, formu …
  • Senzime AB (SEZI)：医療機器：M&Aディール及び事業提携情報
    Summary Senzime AB (Senzime) is a medical device company that develops patient-oriented monitoring systems. The company's product include TetraGraph monitor, CliniSenz analyzer, and Onzurf probe. Its TetraGraph monitor stimulates, measures, analyzes and displays muscle function in surgical patients …
  • New Gold Inc：企業の戦略・SWOT・財務情報
    New Gold Inc - Strategy, SWOT and Corporate Finance Report Summary New Gold Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • EOG Resources, Inc.：企業の戦略・SWOT・財務分析
    EOG Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary EOG Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Tokyo Seimitsu Co., Ltd. (7729)：企業の財務・戦略的SWOT分析
    Tokyo Seimitsu Co., Ltd. (7729) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Diamond Offshore Drilling, Inc.：企業の戦略・SWOT・財務情報
    Diamond Offshore Drilling, Inc. - Strategy, SWOT and Corporate Finance Report Summary Diamond Offshore Drilling, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Bahrain Telecommunications Company BSC (BATELCO)：企業の戦略的SWOT分析
    Bahrain Telecommunications Company BSC (BATELCO) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competit …
  • SK Telecom Co., Ltd.：戦略・SWOT・企業財務分析
    SK Telecom Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary SK Telecom Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Oncolytics Biotech Inc (ONC)-製薬・医療分野：企業M&A・提携分析
    Summary Oncolytics Biotech Inc (Oncolytics) is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for the treatment of cancer. The company’s lead product, Reolysin, a formulation of the human reovirus, is at Phase II clinical trials indi …
  • Sahacogen (Chonburi) Public Company Limited (SCG)：企業の財務・戦略的SWOT分析
    Sahacogen (Chonburi) Public Company Limited (SCG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Guided Therapeutics Inc (GTHP)：医療機器：M&Aディール及び事業提携情報
    Summary Guided Therapeutics Inc (GTI), formerly SpectRx Inc is a biotechnology company that offers platform technology for the early detection of disease that leads to cancer. The company provides products for the non-invasive cervical cancer detection markets. Its products include luviva, a non-inv …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆